|

Surgery for Locally Unresectable Pancreatic Cancer

RECRUITINGSponsored by Azienda Ospedaliera di Padova
Actively Recruiting
SponsorAzienda Ospedaliera di Padova
Started2025-01-01
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07241663

Summary

Pancreatic cancer is a severe disease often diagnosed at an advanced stage, when surgery is not possible. New chemotherapy treatments can sometimes shrink the tumor and make surgery an option. This study aims to understand if surgery after such treatments can improve survival and quality of life in selected patients treated at expert centers.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients older than 18 years
* Patients able to give informed consent
* Histologically confirmed pancreatic adenocarcinoma
* LAPC stage according to NCCN10 at diagnosis (Figure 1)
* Received at least 4 months of induction chemotherapy
* RECIST 1.1 stable disease (SD) or partial response (PR) after induction therapy
* Patient considered eligible for radical resection by local MDT

Exclusion Criteria:

* Informed consent withdrawal
* Presence of tumor characteristics precluding surgery
* Presence of patient significant comorbidities precluding surgery
* Unavailable pre-induction therapy abdominal imaging
* Pathological confirmation of any tumor different from PDAC

Conditions2

CancerLocally Advanced Pancreatic Adenocarcinoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.